Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (1)
Preemptive olmesartan for the delay or prevention of microalbuminuria in diabetes.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Preemptive olmesartan for the delay or prevention of microalbuminuria in diabetes.
Ingelfinger JR. Preemptive olmesartan for the delay or prevention of microalbuminuria in diabetes. N Engl J Med. 2011 Mar 10; 364(10):970-1.
View in:
PubMed
subject areas
Albuminuria
Angiotensin II Type 1 Receptor Blockers
Blood Pressure
Cardiovascular Diseases
Diabetes Mellitus, Type 2
Humans
Imidazoles
Tetrazoles
authors with profiles
Julie Rich Ingelfinger, M.D.